Skip to main content
Premium Trial:

Request an Annual Quote

Whitehead Institute Will Use Definiens' Imaging Products; Partners May Develop New Software

NEW YORK (GenomeWeb News) — Definiens today said it will provide imaging products  to the Massachusetts Institute of Technology to help it integrate “various components of the imaging supply chain in biological research.”
 
Under the terms of the agreement, Definiens said MIT’s BioImaging Center at the Whitehead Institute will use the company’s Enterprise Image Intelligence products to offer image analysis throughout the organization and will allow MIT to exhibit the products to industry representatives.
 
Definiens said it will consider working with MIT to develop new software or linking platforms in order to tailor the products to the school’s needs.
 
Financial terms of the agreement were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.